ACE inhibition in the treatment of children after renal transplantation

被引:21
作者
Arbeiter, K
Pichler, A
Stemberger, R
Mueller, T
Ruffingshofer, D
Vargha, R
Balzar, E
Aufricht, C
机构
[1] Univ Vienna, Klin Kinder & Jugendheilkunde Wien, AKH Wien, A-1090 Vienna, Austria
[2] AKH Wien, Dept Pediat, A-1090 Vienna, Austria
关键词
ACE inhibitor; renal transplantation; children; hypertension; chronic allograft dysfunction;
D O I
10.1007/s00467-003-1317-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Currently, there are no data available on long-term effects of angiotensin-converting enzyme inhibitors (ACE-I) on graft function in children after renal transplantation. We therefore analyzed all children who were transplanted at our institution between 1989 and 1998 and followed for at least 2 years. Those treated with ACE-I, mainly because of failure of other antihypertensive medications, were compared to those without ACE-I. The ACE-I-treated children (n=19) showed significantly better blood pressure control during the 1st year of follow-up (p<0.05). In children with chronic allograft dysfunction (n=8), treatment with ACE-I stabilized graft function, with improvement in creatinine clearance in 50% (p<0.01). Serum potassium and hemoglobin levels remained stable. One patient discontinued ACE-I because of renal artery stenosis. Taken together, ACE-I were effective and safe in the treatment of hypertension in children following renal transplantation. Children with chronic allograft dysfunction experienced a stabilizing effect on graft function.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 15 条
[1]   REVERSIBLE RENAL-FAILURE DUE TO THE USE OF CAPTOPRIL IN A RENAL-ALLOGRAFT RECIPIENT TREATED WITH CYCLOSPORINE [J].
AHMAD, T ;
COULTHARD, MG ;
EASTHAM, EJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (04) :311-312
[2]  
Benfield M R, 1999, Pediatr Transplant, V3, P152, DOI 10.1034/j.1399-3046.1999.00011.x
[3]  
Falkner B, 1996, PEDIATRICS, V98, P649
[4]  
FIRST MR, 1994, J AM SOC NEPHROL, V4, P30
[5]   ACE inhibitor versus β-blocker for the treatment of hypertension in renal allograft recipients [J].
Hausberg, M ;
Barenbrock, M ;
Hohage, H ;
Müller, S ;
Heidenreich, S ;
Rahn, KH .
HYPERTENSION, 1999, 33 (03) :862-868
[6]   Influence of proteinuria on long-term transplant survival in kidney transplant recipients [J].
Hohage, H ;
Kleyer, U ;
Bruckner, D ;
August, C ;
Zidek, W ;
Spieker, C .
NEPHRON, 1997, 75 (02) :160-165
[7]   Is it time for ACE inhibitors in chronic allograft nephropathy? [J].
Lewis, JB ;
Helderman, JH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :154-156
[8]   Arterial hypertension and renal allograft survival [J].
Mange, KC ;
Cizman, B ;
Joffe, M ;
Feldman, HI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (05) :633-638
[9]   Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril [J].
Midtvedt, K ;
Hartmann, A ;
Foss, A ;
Fauchald, P ;
Nordal, KP ;
Rootwelt, K ;
Holdaas, H .
TRANSPLANTATION, 2001, 72 (11) :1787-1792
[10]   Short-term pediatric renal transplant survival: Blood pressure and allograft function [J].
Mitsnefes, MM ;
Omoloja, A ;
McEnery, PT .
PEDIATRIC TRANSPLANTATION, 2001, 5 (03) :160-165